合計 50 件の最近のインサイダー取引記録が記録されています Deciphera Pharmaceuticals, Inc. (DCPH), 内訳は 27 件の買い および 22 件の売り. インサイダー買い総額は $12.24M インサイダー売り総額は $1.51M.
最近活動のある主要インサイダーには Brightstar Associates Llc, Sherman Matthew L, Kelly Thomas Patrick. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — DCPH
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-04-22 |
Brightstar Associates Llc |
10 Percent Owner |
オプション行使（ITM） |
48,136 |
$0.01 |
$481.36 |
- |
| 2024-02-16 |
Sherman Matthew L |
EVP & Chief Medical Officer |
情報に基づく売り |
2,615 |
$15.62 |
$40.84K |
108,739 |
| 2024-02-16 |
Kelly Thomas Patrick |
Chief Financial Officer |
情報に基づく売り |
3,010 |
$15.62 |
$47.01K |
80,350 |
| 2024-02-16 |
Martin Daniel C. |
Chief Commercial Officer |
情報に基づく売り |
2,267 |
$15.62 |
$35.41K |
55,118 |
| 2024-02-16 |
Pitman Jama |
SVP, Chief Development Officer |
情報に基づく売り |
2,267 |
$15.62 |
$35.41K |
68,031 |
| 2024-02-15 |
Sherman Matthew L |
EVP & Chief Medical Officer |
RSU 付与（制限付株式） |
69,100 |
$15.92 |
$1.1M |
69,100 |
| 2024-02-15 |
Kelly Thomas Patrick |
Chief Financial Officer |
RSU 付与（制限付株式） |
69,100 |
$15.92 |
$1.1M |
69,100 |
| 2024-02-15 |
Hoerter Steven L. |
President and CEO |
RSU 付与（制限付株式） |
298,100 |
$15.92 |
$4.75M |
298,100 |
| 2024-02-15 |
Martin Daniel C. |
Chief Commercial Officer |
RSU 付与（制限付株式） |
38,900 |
$15.92 |
$619.29K |
38,900 |
| 2024-02-15 |
Dhanak Dashyant |
EVP & Chief Scientific Officer |
RSU 付与（制限付株式） |
69,100 |
$15.92 |
$1.1M |
69,100 |
| 2024-02-15 |
Pitman Jama |
SVP, Chief Development Officer |
RSU 付与（制限付株式） |
38,900 |
$15.92 |
$619.29K |
38,900 |
| 2024-02-07 |
Brightstar Associates Llc |
10 Percent Owner |
オプション行使（ITM） |
914,001 |
$0.01 |
$9.14K |
48,136 |
| 2024-01-16 |
Sherman Matthew L |
EVP & Chief Medical Officer |
情報に基づく売り |
2,435 |
$14.47 |
$35.23K |
94,079 |
| 2024-01-16 |
Allen Patricia L |
Director |
RSU 付与（制限付株式） |
4,727 |
$14.46 |
$68.35K |
4,727 |
| 2024-01-16 |
Kelly Thomas Patrick |
Chief Financial Officer |
情報に基づく売り |
2,435 |
$14.47 |
$35.23K |
66,085 |
| 2024-01-16 |
Squarer Ron |
Director |
RSU 付与（制限付株式） |
4,727 |
$14.46 |
$68.35K |
4,727 |
| 2024-01-16 |
Walsh Dennis Leo |
Director |
RSU 付与（制限付株式） |
4,727 |
$14.46 |
$68.35K |
4,727 |
| 2024-01-16 |
Martin Daniel C. |
Chief Commercial Officer |
情報に基づく売り |
1,624 |
$14.47 |
$23.5K |
47,660 |
| 2024-01-16 |
Friedman Franklin Stuart |
Director |
RSU 付与（制限付株式） |
4,727 |
$14.46 |
$68.35K |
4,727 |
| 2024-01-16 |
Pitman Jama |
SVP, Chief Development Officer |
情報に基づく売り |
1,624 |
$14.47 |
$23.5K |
50,573 |
| 2023-12-13 |
Sherman Matthew L |
EVP & Chief Medical Officer |
情報に基づく売り |
2,792 |
$15.37 |
$42.9K |
96,514 |
| 2023-12-13 |
Kelly Thomas Patrick |
Chief Financial Officer |
情報に基づく売り |
2,792 |
$15.37 |
$42.9K |
68,520 |
| 2023-12-13 |
Hoerter Steven L. |
President and CEO |
情報に基づく売り |
30,664 |
$15.37 |
$471.22K |
72,763 |
| 2023-12-13 |
Martin Daniel C. |
Chief Commercial Officer |
情報に基づく売り |
1,727 |
$15.37 |
$26.54K |
49,284 |
| 2023-12-13 |
Pitman Jama |
See Remarks |
情報に基づく売り |
1,662 |
$15.37 |
$25.54K |
52,197 |
| 2023-12-12 |
Sherman Matthew L |
EVP & Chief Medical Officer |
RSU 付与（制限付株式） |
8,244 |
- |
- |
99,306 |
| 2023-12-12 |
Kelly Thomas Patrick |
Chief Financial Officer |
RSU 付与（制限付株式） |
8,244 |
- |
- |
71,312 |
| 2023-12-12 |
Hoerter Steven L. |
President and CEO |
RSU 付与（制限付株式） |
62,500 |
- |
- |
103,427 |
| 2023-12-12 |
Martin Daniel C. |
Chief Commercial Officer |
RSU 付与（制限付株式） |
5,576 |
- |
- |
51,011 |
| 2023-12-12 |
Pitman Jama |
See Remarks |
RSU 付与（制限付株式） |
5,576 |
- |
- |
53,859 |
| 2023-11-30 |
Martin Daniel C. |
Chief Commercial Officer |
情報に基づく売り |
17,801 |
$12.57 |
$223.76K |
45,435 |
| 2023-10-30 |
Sherman Matthew L |
EVP & Chief Medical Officer |
情報に基づく売り |
2,360 |
$12.02 |
$28.36K |
90,628 |
| 2023-10-30 |
Kelly Thomas Patrick |
Chief Financial Officer |
情報に基づく売り |
2,316 |
$12.02 |
$27.83K |
63,068 |
| 2023-10-30 |
Hoerter Steven L. |
President and CEO |
情報に基づく売り |
21,573 |
$12.02 |
$259.26K |
40,927 |
| 2023-10-30 |
Martin Daniel C. |
Chief Commercial Officer |
情報に基づく売り |
1,407 |
$12.02 |
$16.91K |
62,884 |
| 2023-10-30 |
Pitman Jama |
See Remarks |
情報に基づく売り |
1,407 |
$12.02 |
$16.91K |
48,283 |
| 2023-10-28 |
Sherman Matthew L |
EVP & Chief Medical Officer |
RSU 付与（制限付株式） |
8,244 |
- |
- |
92,988 |
| 2023-10-28 |
Kelly Thomas Patrick |
Chief Financial Officer |
RSU 付与（制限付株式） |
8,244 |
- |
- |
65,384 |
| 2023-10-28 |
Hoerter Steven L. |
President and CEO |
RSU 付与（制限付株式） |
62,500 |
- |
- |
62,500 |
| 2023-10-28 |
Martin Daniel C. |
Chief Commercial Officer |
RSU 付与（制限付株式） |
5,576 |
- |
- |
64,291 |
| 2023-10-28 |
Pitman Jama |
See Remarks |
RSU 付与（制限付株式） |
5,576 |
- |
- |
49,690 |
| 2023-10-02 |
Sherman Matthew L |
EVP & Chief Medical Officer |
情報に基づく売り |
2,942 |
$12.68 |
$37.3K |
84,744 |
| 2023-09-15 |
Dhanak Dashyant |
EVP & Chief Scientific Officer |
RSU 付与（制限付株式） |
65,900 |
- |
- |
65,900 |
| 2023-09-05 |
Dhanak Dashyant |
Officer |
不明 |
- |
- |
- |
- |
| 2023-06-21 |
Allen Patricia L |
Director |
RSU 付与（制限付株式） |
30,000 |
$14.91 |
$447.3K |
30,000 |
| 2023-06-21 |
Squarer Ron |
Director |
RSU 付与（制限付株式） |
30,000 |
$14.91 |
$447.3K |
30,000 |
| 2023-06-21 |
Kelley Susan L. |
Director |
RSU 付与（制限付株式） |
30,000 |
$14.91 |
$447.3K |
30,000 |
| 2023-06-21 |
Benz Edward J. Jr |
Director |
RSU 付与（制限付株式） |
30,000 |
$14.91 |
$447.3K |
30,000 |
| 2023-06-21 |
Walsh Dennis Leo |
Director |
RSU 付与（制限付株式） |
30,000 |
$14.91 |
$447.3K |
30,000 |
| 2023-06-21 |
Martin John Richard |
Director |
RSU 付与（制限付株式） |
30,000 |
$14.91 |
$447.3K |
30,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
